Single-Cell RNA Sequencing Unifies Developmental Programs of Esophageal and Gastric Intestinal Metaplasia.


Journal

Cancer discovery
ISSN: 2159-8290
Titre abrégé: Cancer Discov
Pays: United States
ID NLM: 101561693

Informations de publication

Date de publication:
02 06 2023
Historique:
received: 27 07 2022
revised: 30 11 2022
accepted: 14 03 2023
medline: 5 6 2023
pubmed: 18 3 2023
entrez: 17 3 2023
Statut: ppublish

Résumé

Intestinal metaplasia in the esophagus (Barrett's esophagus IM, or BE-IM) and stomach (GIM) are considered precursors for esophageal and gastric adenocarcinoma, respectively. We hypothesize that BE-IM and GIM follow parallel developmental trajectories in response to differing inflammatory insults. Here, we construct a single-cell RNA-sequencing atlas, supported by protein expression studies, of the entire gastrointestinal tract spanning physiologically normal and pathologic states including gastric metaplasia in the esophagus (E-GM), BE-IM, atrophic gastritis, and GIM. We demonstrate that BE-IM and GIM share molecular features, and individual cells simultaneously possess transcriptional properties of gastric and intestinal epithelia, suggesting phenotypic mosaicism. Transcriptionally E-GM resembles atrophic gastritis; genetically, it is clonal and has a lower mutational burden than BE-IM. Finally, we show that GIM and BE-IM acquire a protumorigenic, activated fibroblast microenvironment. These findings suggest that BE-IM and GIM can be considered molecularly similar entities in adjacent organs, opening the path for shared detection and treatment strategies. Our data capture the gradual molecular and phenotypic transition from a gastric to intestinal phenotype (IM) in the esophagus and stomach. Because BE-IM and GIM can predispose to cancer, this new understanding of a common developmental trajectory could pave the way for a more unified approach to detection and treatment. See related commentary by Stachler, p. 1291. This article is highlighted in the In This Issue feature, p. 1275.

Identifiants

pubmed: 36929873
pii: 718812
doi: 10.1158/2159-8290.CD-22-0824
pmc: PMC10236154
mid: EMS172799
doi:

Substances chimiques

RNA 63231-63-0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1346-1363

Subventions

Organisme : Medical Research Council
ID : MR/W014122/1
Pays : United Kingdom
Organisme : Department of Health
ID : BRC-1215-20014
Pays : United Kingdom
Organisme : Cancer Research UK
ID : G102382
Pays : United Kingdom
Organisme : Medical Research Council
ID : RG86932
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2023 The Authors; Published by the American Association for Cancer Research.

Références

Gut. 2022 Aug;71(8):1488-1514
pubmed: 35725291
Science. 2015 Jan 23;347(6220):1260419
pubmed: 25613900
Nature. 2017 Jan 12;541(7636):169-175
pubmed: 28052061
Gut. 2002 Apr;50(4):451-9
pubmed: 11889061
Br J Cancer. 2016 Aug 9;115(4):403-10
pubmed: 27441494
Cell Rep. 2020 May 19;31(7):107628
pubmed: 32433953
Nat Rev Gastroenterol Hepatol. 2015 Jan;12(1):50-60
pubmed: 25365976
Cancer Discov. 2022 Jan;12(1):31-46
pubmed: 35022204
Am J Surg Pathol. 2002 Aug;26(8):1032-9
pubmed: 12170090
Nat Immunol. 2019 Feb;20(2):163-172
pubmed: 30643263
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Curr Opin Genet Dev. 2001 Oct;11(5):581-6
pubmed: 11532402
Nat Commun. 2022 Mar 17;13(1):1407
pubmed: 35301290
Genes Dev. 2022 Jan 1;36(1-2):38-52
pubmed: 34969824
Nature. 2019 Oct;574(7779):532-537
pubmed: 31645730
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Gut. 2002 Sep;51(3):316-22
pubmed: 12171950
Cell. 2011 Jun 24;145(7):1023-35
pubmed: 21703447
J Natl Cancer Inst. 1980 Aug;65(2):231-40
pubmed: 6931245
Nature. 2017 Oct 26;550(7677):529-533
pubmed: 29019984
Cancer Cell. 2012 Jan 17;21(1):36-51
pubmed: 22264787
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Nat Genet. 2016 Oct;48(10):1131-41
pubmed: 27595477
J Exp Med. 2020 Feb 3;217(2):
pubmed: 31753849
J Natl Cancer Inst. 2011 Jul 6;103(13):1049-57
pubmed: 21680910
Int J Mol Sci. 2017 Sep 27;18(10):
pubmed: 28953255
Gastroenterology. 2011 Mar;140(3):1084-91
pubmed: 21376940
Clin Cancer Res. 2020 Jun 1;26(11):2640-2653
pubmed: 32060101
Cancer Cell. 2018 Apr 9;33(4):721-735.e8
pubmed: 29622466
Am J Gastroenterol. 2016 Jan;111(1):30-50; quiz 51
pubmed: 26526079
Gastroenterology. 2018 Jul;155(1):67-75
pubmed: 29550592
Gastroenterology. 2022 Apr;162(4):1197-1209.e13
pubmed: 34973296
Gastroenterology. 2020 Dec;159(6):2116-2129.e4
pubmed: 32835664
Nature. 2021 Sep;597(7875):250-255
pubmed: 34497389
Nucleic Acids Res. 2016 Jul 27;44(13):e117
pubmed: 27179027
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
World J Gastroenterol. 2005 Oct 28;11(40):6360-5
pubmed: 16419166
Gut. 2020 Jun;69(6):1027-1038
pubmed: 31481545
Nat Biotechnol. 2018 Jun;36(5):421-427
pubmed: 29608177
Nat Commun. 2019 Jan 22;10(1):380
pubmed: 30670690
Aliment Pharmacol Ther. 2014 Jun;39(11):1321-30
pubmed: 24738722
Am J Surg Pathol. 2000 Mar;24(3):402-9
pubmed: 10716154
Science. 2021 Aug 13;373(6556):760-767
pubmed: 34385390
Dig Dis Sci. 2018 Aug;63(8):2052-2058
pubmed: 29671160
J Gastroenterol Hepatol. 2016 May;31(5):953-8
pubmed: 26630310
Clin Transl Gastroenterol. 2021 Oct 1;12(10):e00402
pubmed: 34597278
Gut. 2014 Jan;63(1):7-42
pubmed: 24165758
Cancer Discov. 2022 Mar 1;12(3):670-691
pubmed: 34642171
Hum Pathol. 2009 Jan;40(1):65-74
pubmed: 18755496
Nat Biotechnol. 2014 Apr;32(4):381-386
pubmed: 24658644
Gut Liver. 2015 Jan;9(1):5-17
pubmed: 25547086
Nature. 2019 Feb;566(7745):496-502
pubmed: 30787437
Gastroenterol Hepatol (N Y). 2018 Feb;14(2):92-101
pubmed: 29606921
Gastric Cancer. 2020 Sep;23(5):811-823
pubmed: 32215766
N Engl J Med. 2018 Mar 22;378(12):1085-1095
pubmed: 29562147
Am J Gastroenterol. 2000 Apr;95(4):921-4
pubmed: 10763938
Nat Rev Mol Cell Biol. 2002 Mar;3(3):187-94
pubmed: 11994739
Theranostics. 2021 Mar 5;11(10):4975-4991
pubmed: 33754039
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Am J Surg Pathol. 2001 Jan;25(1):87-94
pubmed: 11145256
Cell Rep. 2019 May 7;27(6):1934-1947.e5
pubmed: 31067475
Gastroenterology. 2008 Apr;134(4):945-52
pubmed: 18395075
Bioinformatics. 2012 Jul 15;28(14):1811-7
pubmed: 22581179
Nat Genet. 2019 Mar;51(3):506-516
pubmed: 30718927
Am J Surg Pathol. 1996 Oct;20(10):1161-81
pubmed: 8827022
Nat Commun. 2018 Oct 15;9(1):4261
pubmed: 30323168
N Engl J Med. 2014 Aug 28;371(9):836-45
pubmed: 25162890
Nat Rev Dis Primers. 2019 May 23;5(1):35
pubmed: 31123267
Gut. 2017 Aug;66(8):1355-1357
pubmed: 27196579
Front Immunol. 2020 May 15;11:940
pubmed: 32499786
Gastroenterology. 2013 Oct;145(4):730-9
pubmed: 23796455

Auteurs

Karol Nowicki-Osuch (K)

Irving Institute for Cancer Dynamics, Columbia University, New York, New York.
New York Genome Center, New York, New York.

Lizhe Zhuang (L)

Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.

Tik Shing Cheung (TS)

School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.

Emily L Black (EL)

Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.

Neus Masqué-Soler (N)

Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.

Ginny Devonshire (G)

Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.

Aisling M Redmond (AM)

Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.

Adam Freeman (A)

Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.

Massimilliano di Pietro (M)

Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.

Nastazja Pilonis (N)

Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Wladyslaw Januszewicz (W)

Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Maria O'Donovan (M)

Cambridge University Hospital NHS Trust, Cambridge, United Kingdom.

Simon Tavaré (S)

Irving Institute for Cancer Dynamics, Columbia University, New York, New York.
New York Genome Center, New York, New York.
Cambridge University Hospital NHS Trust, Cambridge, United Kingdom.

Jacqueline D Shields (JD)

School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom.

Rebecca C Fitzgerald (RC)

Early Cancer Institute, University of Cambridge, Cambridge, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH